Unleash the Future of Investigating Cardiometabolic Diseases

Embark on a transformative journey with 3D BioSol™ AT Chemically-induced Obesity Organoids (CIOO), a pioneering amalgamation of 3D BioSolTM AT derived from healthy human donor cells (primary SVF of the adipose tissue). Through our proprietary methods, media kit, and expertly crafted cocktails, this powerful model induces progressive adipose tissue (AT) dysfunction, encompassing insulin resistance, adipocyte hypertrophy, and fibrosis.

Key Features:

• Comprehensive Model: Encompasses all critical AT cells and inducers, faithfully replicating the evolution of human AT disease in vitro.
• Versatile Applications: Ideal for investigating mechanisms of adipocyte hypertrophy induced by Nutritional Perturbation (AT dysfunction), screening anti-Obesity drugs, and evaluating drug candidates' safety within a contextually relevant disease framework.

Commence on a new era of research, unlocking the potential of 3D BioSol™ AT Chemically-induced Obesity Organoids (CIOO) for a deeper understanding of adipose tissue dysfunction and advancing drug development.

Immerse yourself in the unique capabilities of 3D BioSol™ AT PDOO, featuring 96- or 384-well plates housing mini-organs derived from human patients with BMIs ranging from 30 to 60, along with healthy controls at BMIs of 25-27. Unparalleled in the market, this platform provides unmatched versatility.

Customize your plates to perfection by specifying the number of patients and BMI ranges, creating unique mixes with diverse patient cells. Backed by meticulously documented patient histories, encompassing details like gender, race, and prevalent diseases, our model offers an ideal framework for assessing compound effects while considering crucial population characteristics.

Unlock tailored insights and elevate your research with 3D BioSol™ AT PDOO—where versatility meets precision.